Parvesh K. Singh
Chiltern Hill
Durban, ZN 4000, South Africa
Durban, ZN 4000, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Development of Isoniazid-Pyrazole Hybrids as Potential Antitubercular Agents.
Journal: International journal of molecular sciences
Published: April 15, 2026
Antidiabetic Evaluation of Thiosemicarbazone Analogs Through α-Amylase Inhibition Complemented With Computational Studies.
Journal: Chemistry & biodiversity
Published: March 13, 2026
Antidiabetic and Cytotoxicity Studies of Novel Quinazolinone-1,3,4-Thiadiazole Molecular Hybrids.
Journal: Chemistry & biodiversity
Published: January 26, 2026
Rational Design and Antimycobacterial Evaluation of Aryl Sulfonamide-Linked Isoniazid Hydrazones Against Mycobacterium Tuberculosis.
Journal: ChemMedChem
Published: May 20, 2025
Rationally Designed InhA Inhibitors: A Comparative Anti-Tubercular Activity Study of Sulfonate Esters of Isoniazid Hydrazones and Their Structurally Flexible Benzyl Analogues.
Journal: Chemical biology & drug design
Published: April 18, 2025
One-Pot Synthesis of Novel β-Carboline-{α-Acylaminoamide}-Bisindole Derivatives: Antibacterial Evaluation, Molecular Docking, and Density Functional Theory Studies.
Journal: ChemistryOpen
Published: April 17, 2025
DES-Promoted Synthesis of 3,4-Dihydropyrimidinones and Their Antidiabetic and Antioxidant Evaluation Supported With Computational Studies.
Journal: Chemistry & biodiversity
Published: March 19, 2025
Antidiabetic Evaluation of New Pyrimidine-Thiazoline Hybrids Endorsed With Enzyme Kinetic Studies and Computational Analysis.
Journal: Chemical biology & drug design
Published: January 21, 2025
Isoniazid-Dihydropyrimidinone Molecular Hybrids: Design, Synthesis, Antitubercular Activity, and Cytotoxicity Investigations with Computational Validation.
Journal: ChemMedChem
Published: November 25, 2024
Last Updated: 09/26/2026